281 related articles for article (PubMed ID: 30370251)
21. Bone marrow microenvironment: The guardian of leukemia stem cells.
Houshmand M; Blanco TM; Circosta P; Yazdi N; Kazemi A; Saglio G; Zarif MN
World J Stem Cells; 2019 Aug; 11(8):476-490. PubMed ID: 31523368
[TBL] [Abstract][Full Text] [Related]
22. Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia.
Ladikou EE; Sivaloganathan H; Pepper A; Chevassut T
Curr Oncol Rep; 2020 Feb; 22(3):27. PubMed ID: 32048054
[TBL] [Abstract][Full Text] [Related]
23. Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
Borella G; Da Ros A; Borile G; Porcù E; Tregnago C; Benetton M; Marchetti A; Bisio V; Montini B; Michielotto B; Cani A; Leszl A; Campodoni E; Sandri M; Montesi M; Bresolin S; Cairo S; Buldini B; Locatelli F; Pigazzi M
Blood; 2021 Aug; 138(7):557-570. PubMed ID: 34010415
[TBL] [Abstract][Full Text] [Related]
24. Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche.
Deng J; Tan Y; Xu Z; Wang H
Ann Hematol; 2024 Apr; ():. PubMed ID: 38684510
[TBL] [Abstract][Full Text] [Related]
25. STING-activating cyclic dinucleotide-manganese nanoparticles evoke robust immunity against acute myeloid leukemia.
Aikins ME; Sun X; Dobson H; Zhou X; Xu Y; Lei YL; Moon JJ
J Control Release; 2024 Apr; 368():768-779. PubMed ID: 38492861
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic targeting of leukemia stem cells in acute myeloid leukemia.
Barbosa K; Deshpande AJ
Front Oncol; 2023; 13():1204895. PubMed ID: 37601659
[TBL] [Abstract][Full Text] [Related]
27. Theranostics in Hematooncology.
Buck AK; Serfling SE; Kraus S; Samnick S; Dreher N; Higuchi T; Rasche L; Einsele H; Werner RA
J Nucl Med; 2023 Jul; 64(7):1009-1016. PubMed ID: 37290799
[TBL] [Abstract][Full Text] [Related]
28. Optimized multiplex immunofluorescence for the characterization of tumor immune microenvironment in neoplastic paraffin-preserved tissues.
Roversi FM; Bueno MLP; da Silva JAF; Assis-Mendonça GR; Saad STO
J Cell Commun Signal; 2023 Sep; 17(3):1055-1065. PubMed ID: 37191838
[TBL] [Abstract][Full Text] [Related]
29. Cancer-associated fibroblasts in acute leukemia.
Gu L; Liao P; Liu H
Front Oncol; 2022; 12():1022979. PubMed ID: 36601484
[TBL] [Abstract][Full Text] [Related]
30. Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia.
Weeda V; Mestrum SGC; Leers MPG
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142442
[TBL] [Abstract][Full Text] [Related]
31. Hedgehog/GLI signaling in hematopoietic development and acute myeloid leukemia-From bench to bedside.
Tesanovic S; Krenn PW; Aberger F
Front Cell Dev Biol; 2022; 10():944760. PubMed ID: 35990601
[TBL] [Abstract][Full Text] [Related]
32. Modelling acute myeloid leukemia (AML): What's new? A transition from the classical to the modern.
Dozzo A; Galvin A; Shin JW; Scalia S; O'Driscoll CM; Ryan KB
Drug Deliv Transl Res; 2023 Aug; 13(8):2110-2141. PubMed ID: 35930221
[TBL] [Abstract][Full Text] [Related]
33. Bone Marrow Microenvironment-On-Chip for Culture of Functional Hematopoietic Stem Cells.
Sharipol A; Lesch ML; Soto CA; Frisch BJ
Front Bioeng Biotechnol; 2022; 10():855777. PubMed ID: 35795163
[TBL] [Abstract][Full Text] [Related]
34. Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia.
Kiani-Zadeh M; Rezvany MR; Namjoo S; Barati M; Mohammadi MH; Ghasemi B; Tabatabaei T; Ghavamzadeh A; Zaker F; Teimoori-Toolabi L
Mol Biol Rep; 2022 Aug; 49(8):7849-7862. PubMed ID: 35733068
[TBL] [Abstract][Full Text] [Related]
35. TIGIT axis: novel immune checkpoints in anti-leukemia immunity.
Qiu D; Liu X; Wang W; Jiang X; Wu X; Zheng J; Zhou K; Kong X; Wu X; Jin Z
Clin Exp Med; 2023 Jun; 23(2):165-174. PubMed ID: 35419661
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Value of
Morad HM; Abou-Elzahab MM; Aref S; El-Sokkary AMA
ACS Omega; 2022 Mar; 7(9):8128-8140. PubMed ID: 35284729
[TBL] [Abstract][Full Text] [Related]
37. The KRAS-G12D mutation induces metabolic vulnerability in B-cell acute lymphoblastic leukemia.
Xu Y; Fang H; Chen Y; Tang Y; Sun H; Kong Z; Yang F; Kirschner-Schwabe R; Zhu L; Toker A; Xiao N; Zhou BS; Li H
iScience; 2022 Mar; 25(3):103881. PubMed ID: 35243242
[TBL] [Abstract][Full Text] [Related]
38. Put in a "Ca
Lewuillon C; Laguillaumie MO; Quesnel B; Idziorek T; Touil Y; Lemonnier L
Cells; 2022 Feb; 11(3):. PubMed ID: 35159351
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticle-Mediated Delivery of Micheliolide Analogs to Eliminate Leukemic Stem Cells in the Bone Marrow.
Ackun-Farmmer MA; Alwaseem H; Counts M; Bortz A; Giovani S; Frisch BJ; Fasan R; Benoit DSW
Adv Ther (Weinh); 2022 Jan; 5(1):. PubMed ID: 35097186
[TBL] [Abstract][Full Text] [Related]
40. Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression.
Cai H; Kondo M; Sandhow L; Xiao P; Johansson AS; Sasaki T; Zawacka-Pankau J; Tryggvason K; Ungerstedt J; Walfridsson J; Ekblom M; Qian H
Blood; 2022 May; 139(20):3040-3057. PubMed ID: 34958665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
